Pacira Pharmaceuticals reported $34.65M in Cost of Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acelrx Pharmaceuticals ACRX:US $ 0.44M 0.6M
Adamas Pharmaceuticals ADMS:US 576K 49K
Aerie Pharmaceuticals AERI:US $ 7.9M 1.72M
Amerisourcebergen ABC:US $ 56843.01M 5325.52M
Astellas Pharma 4503:JP Y 62505M 274M
Biodelivery Sciences International BDSI:US $ 6.36M 2.08M
Bristol Myers Squibb BMY:US $ 2291M 160M
Coherus Biosciences CHRS:US $ 21.28M 4.58M
Depomed DEPO:US $ 3.05M 0.87M
Endo International Ordinary Shares ENDP:US $ 297.12M 16.31M
Flexion Therapeutics FLXN:US $ 3.73M 1.25M
Heron Therapeutics HRTX:US $ 11.35M 3.17M
Horizon Pharma HZNP:US $ 251.64M 50.64M
Ironwood Pharmaceuticals IRWD:US $ 0M 0M
JAZZ PHA JAZZ:US $ 145.22M 26.03M
Johnson & Johnson JNJ:US $ 7250M 317M
Lannett LCI:US $ 85M 1.65M
Ligand Pharmaceuticals LGND:US $ 11.45M 19.15M
Nektar Therapeutics NKTR:US $ 5.31M 2.36M
Omeros OMER:US $ 333K 9K
Pacira Pharmaceuticals PCRX:US $ 34.65M 0.6M
Perrigo Ordinary Shares PRGO:US $ 706.3M 74.2M
Pfizer PFE:US $ 9931M 2939M
Revance Therapeutics RVNC:US $ 5.89M 460K
Supernus Pharmaceuticals SUPN:US $ 18.08M 6.94M
Teva Pharmaceutical TEVA:IT 1.99B 2M
Xeris Pharmaceuticals Inc XERS:US $ 3.22M 163K
Zoetis ZTS:US $ 582M 18M